$6.68
-0.04 (-0.52%)
BioScrip, Inc. (NASDAQ:BIOS)
CAPS Rating:
The Company provides pharmaceutical and pharmacy benefit management services.
The Company provides pharmaceutical and pharmacy benefit management services.